top
Search terms
Results 1 - 7 of 7 - ordered by :
Ehjcvp

Recent data from seven European countries show a much better adherence to evidence and recommendations for oral anticoagulation.1 Interestingly, NOACs were given to younger patients and only to 6% of ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Rocio Hinojar, Jose Julio Jiménez-Natcher, Covadonga Fernández-Golfín, Jose Luis Zamorano

Date : 01/04/2015 Item size : 312462 bytes
Ehjcvp

An index of new research activity in Cardiovascular Pharmacotherapy can be obtained by listing the number of new updates in the 8th edition of Drugs for the Heart2 that covers all the main areas of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Lionel H. Opie

Date : 01/04/2015 Item size : 144582 bytes
Ehjcvp

New oral anticoagulants are used in atrial fibrillation (AF) patients to prevent strokes in the primary and secondary prevention settings.1,2 Since AF are reported to be an independent risk factor ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Shinichi Goto, Shinya Goto

Date : 01/04/2015 Item size : 186244 bytes
Ehjcvp

Furthermore, even the truth changes since we perform new studies and since people challenge the truth When I was in Medical School one professor of Medicine told the class, Damn you if you treat ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/04/2015 Item size : 97793 bytes
Ehjcvp

Abstract Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. Using a ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 01/01/2017 Item size : 240628 bytes
Ehjcvp

In this issue of the journal, Dr Vries and co-workers report data from a study that aimed to explore the level of agreement between windows for different platelet function tests (PFTs) used to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/01/2017 Item size : 132260 bytes
Ehjcvp

Using a Cox proportional hazard model adjusting for baseline characteristics, use of apixaban [hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.610.80, P0.001] and dabigatran (HR 0.74, 95% CI ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 27/09/2016